ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

Barney Lepovetsky Dead At 64

April 6, 1990

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

March 27, 2009

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001